Thought leaders Featured in the bonus digital articles
Julian Adams, Ph.D. President, Research and Development and Chief Scientific Officer, Infinity Pharmaceuticals Inc.
Brent Ahrens. General Partner, Canaan Partners
Kenneth C. Aldrich. CEO, Chairman, and Co-Founder, International Stem Cell Corp.
Meryl Allison. Principal, Deloitte Consulting
Karla Anderson. Managing Director, Pharmaceuticals and Life-Sciences, Advisory Services Group, PricewaterhouseCoopers
Kelly Andrews. Director, Strategic Planning, MicroMass
Sam Azoulay. Senior VP, Medical & Development, Emerging Markets Business Unit, Pfizer Inc.
Jeff Baker. President and CEO, Noble Marketing Group
Joseph Baron. Partner, Extera Partners
Greg Barrett. VP of Marketing, Daiichi Sankyo
Nancy Beesley. Executive VP, Client Services, HC&B Healthcare Communications
Tim Bertram, D.V.M., Ph.D. Senior VP, Science and Technology, Tengion
Wendy Blackburn. Executive VP, Intouch Solutions
Chris Bode, Ph.D. VP, Corporate Development, Absorption Systems LP
Paul Boni. Chief Research Officer, Grail Research
Katrine Bosley. CEO, Avila Therapeutics Inc.
Jesse Bowden. President, Imaging Services, Biomedical Systems
Bonnie Brescia. Founding Principal, BBK Worldwide
Patrick Brundage. Practice Leader, Enterprise Analytics Practice, Cognizant
Carolyn Buck Luce. Global Pharmaceutical Leader, Ernst & Young
Neil Campbell. Chairman and CEO, Mosaigen
Faruk Capan. CEO, Intouch Solutions
Jay Carter. Senior VP, Director of Client Services, AbelsonTaylor
Bob Celeste. Director, GS1 Healthcare US
Sam Chakraborty. Senior Director, SSA & Co.
Michael N. Chang, Ph.D. President and CEO, Optimer Pharmaceuticals Inc.
Tony Chant. Managing Director, Eurocom Healthcare Communications
Dave Chapman. Managing Partner, CommonHealth
Todd Clark. President, Value of Insight Consulting Inc.
Patrick Collins. President, 5th Finger
Nick Colucci. President and CEO, Publicis Healthcare Communications Group
Terri Cooper, Ph.D. Principal, Deloitte Consulting LLP
Ben Currie. Emerging Technologies, Purohit Navigation
Lisa Davis. VP, Corporate Communications, AstraZeneca US
Jim Dayton. Emerging Media Director, Intouch Solutions
Evan Demesthas, M.D., R.PH. CEO, The Medical Affairs Company
Phil Deschamps. CEO and President, GSW Worldwide
Robert Dickinson. Client Service Officer, Life Sciences Practice, Grail Research
Paul Dreyer. Chief Commercial Strategist, Friday Morning
Matthew Eberhart. Global Business Development Leader, Quintiles Consulting
Todd Everhart, M.D., FACP. Director, Medical Affairs, Americas, Chiltern
Karen Ferrante, M.D. Senior VP, Clinical, Millennium: The Takeda Oncology Company
Astrid Frank. General Manager, Fisher Clinical Services
Laurie Halloran. President and CEO, Halloran Consulting Group
Michael J. Harte. Founder and President, Harte Group
Simon Higginbotham. Senior VP and Chief Marketing Officer, Kendle
Terry Hisey. Vice Chairman and U.S. Industry Leader, Life Sciences Practice, Deloitte LLP
Bill Hook. VP of Global Strategy, Healthcare Logistics, UPS Supply Chain Solutions
A. Shabeer Hussain. Programme Leader, Pharmaceutical and Biotechnology, Healthcare, EIA, Frost & Sullivan
Jason Hwang, M.D. Executive Director, Healthcare, Innosight Institute
Jim Jenson, Ph.D. CEO, Dicerna Pharmaceuticals
Jan-Anders Karlsson, Ph.D. CEO of S*BIO Pte Ltd.
Liz Kay. VP, Account Service, Cramer
Rick Keefer. President and CEO, Publicis Strategic Solutions Group
Greg Kirsch. VP, Creative Services of Intouch Solutions
Ryo Kubota, M.D., Ph.D. Chairman, President, and CEO, Acucela
Michael J. Laferrera. Senior VP, Sales and Marketing, J. Knipper & Co. Inc.
Nicholas Landekic. President and CEO, PolyMedix Inc.
Ilyssa Levins. President and Founder, Center for Communication Compliance
Kim Levy. Senior VP, MicroMass Communications
Patrick Lindsay. Executive VP, United BioSource Corp.
Nancy Lurker. CEO, PDI Inc.
Alistair Macdonald. Executive VP, Global Services, INC Research
John MacPhee. President, Strativa Pharmaceuticals
John Maraganore, Ph.D. CEO, Alnylam Pharmaceuticals
JeanMarie Markham. Founder and President, Clinlogix Inc.
Rudiger Mees. CEO, Unithink
David Merkel. Senior VP, Business Solutions, J. Knipper & Co. Inc.
Sylvia Miriyam Findlay. Programme Leader, Pharmaceutical and Biotechnology, Healthcare, Europe, at Frost & Sullivan
Celeste Mosby. VP, Life Sciences, Wilson Learning Worldwide
Mike Myers. President, Palio
Rajesh Nair, MMS, MBA. President and CEO, Indegene
Peter Nalen. CEO, Compass Healthcare Communications
Steven Nichtberger, M.D. President and CEO, Tengion
Lance Nickens. President, The Patient Recruiting Agency
Terry Nugent. VP Marketing, Medical Marketing Service
Michael O’Connell. Director of Life Sciences, Tibco Spotfire Inc.
Dave Ormesher. CEO, Closerlook Inc.
Sanjay Parikh, Ph.D. Director, Indegene
Stuart Peltz, Ph.D. CEO, PTC Therapeutics
Adelene Perkins. President and Chief Business Officer, Infinity Pharmaceuticals Inc.
Joseph Pieroni. President and CEO, Daiichi Sankyo Inc.
Vinod Podichetty, M.D., MS. Chief Scientific Advisor, Research Practice Partners Inc.
Richard F. Pops. Chairman, President, and CEO, Alkermes Inc.
John Potthoff, Ph.D. Chief Operating Officer, INC Research
Beth Price. Executive VP, The Medical Affairs Company
Ahnal Purohit, Ph.D. President and CEO, Purohit Navigation
Mark J. Pykett, V.M.D, MBA. President and Chief Operating Officer, Alseres Pharmaceuticals
Louis Renzetti, Ph.D. VP and Global Head, RNA Therapeutics, Roche
Ken Ribotsky. President and CEO, The Core Nation Inc.
Rick Rosenthal. Principal and Practice Leader, Sales Force Effectiveness, Health Strategies Group
Tom Russell. General Manager of Enterprise Solutions, SciQuest Inc.
Mike Rutstein. Founder and President, StrikeForce Communications LLC
Ed Sellers, M.D., Ph.D. VP, Early Stage, Kendle
Bob Silvers. Managing Director, SSA & Co.
Stephen M. Simes. President and CEO, BioSante Pharmaceuticals
Raj Singh. VP, General Manager, Formedic
Te Smith. VP, Communications, MarkMonitor
Nagaraja Srivatsan. Head of Life Sciences, North America, Cognizant Technology Solutions
Tom Steinke. CEO, Minnow Medical Inc.
Mark Stejbach. VP and Chief Commercial Officer, Tengion
Jeff Stomberg. CEO, Delta Pharma
Jason Stowe. CEO, Cycle Computing
Scott Treiber, Ph.D. Executive VP, Clinical Development Solutions, inVentiv Clinical Solutions
Mark Weinstein. CEO, BioClinica Inc.
James R. Weston. Senior VP, Talaris Advisors LLC
Mike Wexler. Principal, Biltmore Technologies
Roger L. Williams, M.D. CEO, U.S. Pharmacopeial Convention
Dave Womelsdorf. Americas Advisory Leader, Life Sciences, Ernst & Young
Steve Worland. President and CEO, Anadys Pharmaceuticals
Donna Wray. Management Advisor, TGaS Advisors
Steve Wunker. Senior Partner, Innosight
Claire R. Wynters. Business Development Associate, Criterium Inc.
Kleanthis Xanthopoulos, Ph.D. President and CEO, Regulus Therapeutics
Daniel Zurr, Ph.D. CEO and President, Quark Pharmaceuticals Inc.